BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15848586)

  • 1. Successful vaccination against varicella zoster virus prior to kidney transplantation.
    Geel A; Zuidema W; van Gelder T; van Doornum G; Weimar W
    Transplant Proc; 2005 Mar; 37(2):952-3. PubMed ID: 15848586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates.
    Geel AL; Landman TS; Kal JA; van Doomum GJ; Weimar W
    Transplant Proc; 2006 Dec; 38(10):3418-9. PubMed ID: 17175291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients.
    Chaves Tdo S; Lopes MH; de Souza VA; Dos Santos Sde S; Pereira LM; Reis AD; David-Neto E
    Pediatr Transplant; 2005 Apr; 9(2):192-6. PubMed ID: 15787792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella vaccination in HIV-1-infected children after immune reconstitution.
    Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
    AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group.
    Furth SL; Hogg RJ; Tarver J; Moulton LH; Chan C; Fivush BA;
    Pediatr Nephrol; 2003 Jan; 18(1):33-8. PubMed ID: 12488988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella vaccination in children after bone marrow transplantation.
    Sauerbrei A; Prager J; Hengst U; Zintl F; Wutzler P
    Bone Marrow Transplant; 1997 Sep; 20(5):381-3. PubMed ID: 9339753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
    Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
    J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient: should renal patients be vaccinated against VZV before transplantation?
    Robertson S; Newbigging K; Carman W; Jones G; Isles C;
    Clin Transplant; 2006; 20(1):136-8. PubMed ID: 16556169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.